Stock analysts at Maxim Group started coverage on shares of Alterity Therapeutics (NASDAQ:ATHE – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The brokerage set a ...

Alzheimer’s drugs should be prescribed like statins to stave off dementia, one of Britain’s leading neuroscientists has said.

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

The NHS has paid out tens of thousands to a man who developed an “uncontrollable” gambling problem after he was given a common Parkinson’s drug, The Independent can reveal Philip Stevens, a 66 year ...

A Penn Medicine-led consortium of radiology and chemistry researchers across the United States will advance imaging of ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...

The North Chicago-based drugmaker said it's received positive topline results in a Phase 3 trial of its investigational ...

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...

Parkinson disease, stroke, and dementia were 2 to 3 times more prevalent among cases vs controls. This large population-based study has shown that several therapeutic groups, classes, subclasses, and ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

Recent headlines in health news spotlight several pharmaceutical developments: AbbVie's Parkinson's drug shows promise in ...